Elizabeth Czerepak

Elizabeth Czerepak is recorded as Board Member at Transcode Therapeutics, Inc. (RNAZ) since January 1, 2025 and Board Member at Delcath Systems, Inc. (DCTH) since January 1, 2020. The newest filing on record that lists Elizabeth Czerepak as Board Member at Transcode Therapeutics, Inc. (RNAZ) is dated June 2, 2026. The newest filing on record that lists Elizabeth Czerepak as Board Member at Delcath Systems, Inc. (DCTH) is dated April 2, 2026. Delcath Systems, Inc. reported in an 8-K filed May 14, 2026 that Elizabeth Czerepak was appointed Class II director, effective May 13, 2026. Transcode Therapeutics, Inc. reported in an 8-K filed October 8, 2025 that Elizabeth Czerepak was appointed independent board member. Transcode Therapeutics, Inc. reported in an 8-K filed October 8, 2025 that Elizabeth Czerepak was appointed member and chairperson of the Audit Committee, effective October 6, 2025. Equibles holds 5 filed executive changes naming Elizabeth Czerepak; each is listed under recent activity with its source filing. Delcath Systems, Inc. is classified in the Medical Devices industry within the Healthcare sector. Transcode Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Delcath Systems, Inc. includes Gerard Michel (CEO and Board Member), John Purpura (CEO), Sandra Pennell (CFO) and 7 others.